This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Barg, N L Articles by Fekety, R Search for Related Content PubMed PubMed Citation Articles by Barg, N L Articles by Fekety, R

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1986 February; 29(2): 209-211

Persistent staphylococcal bacteremia in an intravenous drug abuser.

ABSTRACT

A patient with methicillin-resistant Staphylococcus aureus bacteremia received vancomycin (MIC = 0.8 microgram/ml, MBC = 15 micrograms/ml) and heparin simultaneously through the same intravenous line to treat a septic deep venous thrombosis. Bacteremia persisted for 7 days. Bacteremia terminated when the simultaneous infusion of heparin and vancomycin through the same line was stopped. This suggested that an interaction between vancomycin and heparin may have occurred, which resulted in a reduction in vancomycin activity. To test for such an interaction, mixtures of heparin and vancomycin in various concentrations were made and tested for antimicrobial activity against the organisms in the patient. A precipitate formed at the concentrations achieved in the intravenous lines, and when the vancomycin concentrations were measured by bioassay, a 50 to 60% reduction in activity was noted. In contrast, when these solutions were prepared and mixed at microgram concentrations, a precipitate was no longer observed, and antimicrobial activity was not reduced. Heparin appeared to interact unfavorably with vancomycin at the concentrations in the intravenous lines when these drugs were administered simultaneously to patients. This may be the cause of poor therapeutic responses to vancomycin in some patients, especially those infected with tolerant organisms.

This article has been cited by other articles:

• Henrickson, K. J., Axtell, R. A., Hoover, S. M., Kuhn, S. M., Pritchett, J., Kehl, S. C., Klein, J. P. (2000). Prevention of Central Venous Catheter-Related Infections and Thrombotic Events in Immunocompromised Children by the Use of Vancomycin/Ciprofloxacin/Heparin Flush Solution: A Randomized, Multicenter, Double-Blind Trial. JCO 18: 1269-1278 [Abstract] [Full Text]  
• Hammett-Stabler, C. A., Johns, T. (1998). Laboratory guidelines for monitoring of antimicrobial drugs. Clin. Chem. 44: 1129-1140 [Abstract] [Full Text]